ABCG2 and neoplasm: The expression of ABC transporters in human lungs is to date still quite controversial: they have been well-studied in lung cancer, where their upregulation confers multidrug resistance to tumor cells, resulting in a poor outcome for patients [12,13]; conversely, reports about their level of expression, localization, and activity in the normal tissue are still conflicting [2,10,11].